How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

43,660 results for

Hypertension Evaluation History

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension

). Please remove one or more studies before adding more. Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension (BUMP) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03334149 (...) at higher risk of hypertension in pregnancy and assess if self-monitoring can identify raised blood pressure earlier. Compare self-monitoring with usual care for women with high blood pressure in pregnancy to see if it leads to lower blood pressure. Assess if self-monitoring is cost-effective. Pregnant women who chose to take part in these studies will be randomised to either usual care or asked to monitor their own blood pressure during their pregnancy in addition to their usual antenatal care

2017 Clinical Trials

22. Diagnosis & Assessment of Hypertension - Renovascular Hypertension

). Fibromuscular dysplasia primarily affects younger (<40 year old) females. As the prevalence of hypertension below age 40 is relatively low, the presence of hypertension at this age more likely indicates either secondary form of hypertension and/or use of drugs/substances causing high blood pressure. In this situation, especially in the absence of an obvious contributor to early onset hypertension (such as obesity), testing for renovascular hypertension appears justified, as fibromuscular dysplasia (...) of stenosis (>70% of the lumen area), pressure gradient over the stenosis (> 21 mmHg), lateralization of renal vein plasma renin activity, high arterial resistance index on Doppler ultrasound, delayed contrast accumulation and excretion on intravenous pyelogram, and impaired renal blood flow in response to angiotensin converting enzyme inhibitor on captopril renogram (these last two methods are not indicated for patients with eGFR , 30 ml/min/1.72 m 2 ) . 3. Patients with hypertension and presenting

2018 Hypertension Canada

23. Diagnosis & Assessment of Hypertension - Endocrine Hypertension

): Patients with paroxysmal, unexplained, liable, and/or severe (BP ≥180/110 mmHg) sustained hypertension refractory to usual antihypertensive therapy; Patients with hypertension and multiple symptoms suggestive of catecholamine excess (eg, headaches, palpitations, sweating, panic attacks, and pallor); Patients with hypertension triggered by b-blockers, monoamine oxidase inhibitors, micturition, or changes in abdominal pressure, surgery, or anesthesia; Patients with incidentally discovered adrenal mass (...) and, therefore, warrant close follow-up especially if strong family history of HTN, multiple medications required pre-op or BP control, older age, and longer duration of HTN . Aldosterone antagonists, particularly spironolactone in low to moderate doses, are quite effectivein idiopathic/bilateral hyperplasia hyperaldosteronism and moderately effective even in those who are not surgical candidates or refuse surgery for aldosterone producing adenomas , reducing both blood pressure, normalizing potassium

2018 Hypertension Canada

24. Hypertension in adults: diagnosis and management

Consider antihypertensive drug treatment in addition to lifestyle advice for people aged over 80 with a clinic blood pressure of over 150/90 mmHg. Use clinical judgement for people with frailty or multimorbidity (see also NICE's guideline on multimorbidity). [2019] [2019] 1.4.14 For adults aged under 40 with hypertension, consider seeking specialist evaluation of secondary causes of hypertension and a more detailed assessment of the long-term balance of treatment benefit and risks. [2019] [2019] T o (...) people with isolated systolic hypertension (systolic blood pressure 160 mmHg or more) the same treatment as people with both raised systolic and diastolic blood pressure. [2004] [2004] 1.4.28 Offer antihypertensive drug treatment to women of childbearing potential with diagnosed hypertension in line with the recommendations in this guideline. For women considering pregnancy or who are pregnant or breastfeeding, manage hypertension in line with the recommendations on management of pregnancy

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

25. Hypertension in pregnancy: diagnosis and management

: diagnosis and management (NG133) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 54This guideline replaces CG107. This guideline is the basis of QS35. Ov Overview erview This guideline covers diagnosing and managing hypertension (high blood pressure), including pre- eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had (...) in adults: diagnosis and treatment. [2019] [2019] 1.3.7 Continue with existing antihypertensive treatment if safe in pregnancy, or switch to an alternative treatment, unless: sustained systolic blood pressure is less than 110 mmHg or or sustained diastolic blood pressure is less than 70 mmHg or or the woman has symptomatic hypotension. [2019] [2019] 1.3.8 Offer antihypertensive treatment to pregnant women who have chronic hypertension and who are not already on treatment if they have: Hypertension

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

26. Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives

) consisting of the antihypertensive drug amlodipine besylate and the non-steroidal anti-inflammatory drug (NSAID) celecoxib. KIT-302 is being developed as a "convenience reformulation" FCDP to facilitate and improve patient compliance with the once a day (qd) administration of its individual components, amlodipine and celecoxib, when used together for the treatment of hypertension, to lower blood pressure, in patients who also require the use of an NSAID for relief of the signs and symptoms (...) of age Existing hypertension that is being treated using pharmacological therapy with a single agent that is not a calcium channel blocker SBPday > 135 and ≤ 169 mmHg and average daytime (9:00 to 21:00) ambulatory diastolic blood pressure (DBPday) ≤ 110 mmHg at Day 0 (after the 10- to 14-day washout from prior blood pressure medication) Body Mass Index of 18.5 to 34.9 kg/m2 Healthy (other than hypertension) as determined by the Investigator based on medical history, physical examination, vital signs

2016 Clinical Trials

27. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents

. Thaker , Elaine M. Urbina , SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN This article has corrections. Please see: Abstract These pediatric hypertension guidelines are an update to the 2004 “Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents.” Significant changes in these guidelines include (1) the replacement of the term “prehypertension” with the term “elevated blood pressure,” (2) new normative pediatric blood (...) of high blood pressure (BP) in children is largely derived from data from the NHANES and typically is based on a single BP measurement session. These surveys, conducted since 1988, indicate that there has been an increase in the prevalence of childhood high BP, including both HTN and elevated BP. , High BP is consistently greater in boys (15%–19%) than in girls (7%–12%). The prevalence of high BP is higher among Hispanic and non-Hispanic African American children compared with non-Hispanic white

2017 American Academy of Pediatrics

28. The Japanese Hypertension Guidelines

[23,24] and death from cancer [24] are higher in people who used antihypertensive drugs as compared with those without the medication. The risk is particularly high in people whose systolic blood pressure is below 120 [25]. In a recent cohort study, JACC study that followed about 28,000 people without cardiovascular disease, cancer, or renal disorder, the risk of death may be higher by 30% in antihypertensive users with lowest Review Review A: Intensive treatment compared with the standard treatment (...) . PMID:9635947 6) Hama R? Intensive lowering blood pressure increase deaths-From HOT and JATE studies. The Informed Prescriber 2001: 16(6):55-58 (in Japanese). 7) Wlielton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AG5/APbA/ASH/ASPC/ NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71: e13-e115. PMID

2020 Med Check - The Informed Prescriber

29. Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: an update

diagnosis is confirmed, pharmacologic treat- ment should not be initiated (Grade C). Masked hypertension occurs when blood pressure is controlled in the office but elevated when out-of-office measurements are conducted Figure 1 Hypertension diagnostic algorithm Elevated BP Reading No Diabetes Diabetes AOBP or non-AOBP = 130/80 No No No Yes Yes Yes White Coat Hypertension Hypertension No Hypertension 1. ABPM (preferred) Daytime mean = 135/85 24-hour mean = 130/80 OR 2. Home BP Series Mean = 135/85 1 (...) pressure, have central obe- sity or have a family history of elevated blood pressure. 53,54 As such, it is recommended to con- duct out-of-office measurements in individuals with such risk factors, even if their office blood pressure was at target. 53,54 It has also been reported that individuals with masked hypertension are at higher risk of car - diovascular events compared to individuals with white coat hypertension and those with normal blood pressure. 55 Figure 2 provides a breakdown

2016 CPG Infobase

30. Essential hypertension

, and Blood Institute. The seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aug 2004 [internet publication]. http://www.nhlbi.nih.gov/files/docs/guidelines/jnc7full.pdf Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-104. https://academic.oup.com/eurheartj/article/39/33/3021/5079119 http://www.ncbi.nlm.nih.gov/pubmed/30165516?tool (...) changes are recommended for all patients: weight loss, exercise, decreased sodium intake, Dietary Approaches to Stop Hypertension (DASH) diet, and moderation of alcohol consumption. Choice of drug therapy is often driven by considerations related to comorbid disease, but achievement of blood pressure goal may be accomplished with a variety of therapeutic agent(s). Definition Essential hypertension is defined as blood pressure (BP) ≥140/90 mmHg, with no secondary cause identified. National Heart, Lung

2019 BMJ Best Practice

31. Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial. (Abstract)

Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial. Hypertension is a risk factor for both stroke and bleeding in patients with atrial fibrillation. Data are sparse regarding the interaction between blood pressure and the efficacy and safety of direct oral anticoagulants. In the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial (...) Fibrillation-Thrombolysis in Myocardial Infarction 48), 19,679 patients with atrial fibrillation and hypertension were categorized according to average systolic blood pressure (SBP) and diastolic blood pressure (DBP). The primary efficacy and safety end points were the time to the first stroke or systemic embolic event and the time to the first International Society of Thrombosis and Hemostasis major bleeding event, respectively. Risk was calculated using Cox proportional hazards models based on average

2019 Hypertension Controlled trial quality: uncertain

32. Essential Hypertension

2003; 362:759. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2008;51:960-969. The 7th report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 2003; 42:1206. Complete report: NHLBI, 2004, NIH Publication No 04-5230. UMHS Hypertension Guideline, May 2014 16 APPENDIX. Standardized Blood Pressure Measurement Types of Measuring Devices • Aneroid manometer could be used. However (...) . Reversible Causes of Sustained Elevated Blood Pressure Readings Medications: • NSAIDs * • oral contraceptive agents • glucocorticoid or mineralocorticoid steroids * interferes with antihypertensive medications Medications (continued): • appetite suppressants • anti-depressants • MAO inhibitors • cyclosporine • erythropoietin Lifestyle factors • alcohol > 2 drinks/day • sedentary lifestyle Illicit drugs • cocaine • amphetamines • anabolic steroids Diet • High sodium (esp. elderly or African-American

2020 University of Michigan Health System

33. Hypertensive emergencies

or eclampsia, in whom systolic BP should be reduced to 140 mmHg within the first hour (120 mmHg in aortic dissection). With appropriate treatment, prognosis is good. Definition Hypertensive emergency is defined as severely elevated blood pressure (BP) associated with new or progressive target organ dysfunction. Although the absolute value of the BP is not as important as the presence of end-organ damage, the systolic BP is usually >180 mmHg and/or the diastolic BP is >120 mmHg. Chobanian AV, Bakris GL (...) , Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52. http://hyper.ahajournals.org/content/42/6/1206.full http://www.ncbi.nlm.nih.gov/pubmed/14656957?tool=bestpractice.com Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report

2018 BMJ Best Practice

34. Essential hypertension

. The seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aug 2004 [internet publication]. http://www.nhlbi.nih.gov/files/docs/guidelines/jnc7full.pdf Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-104. https://academic.oup.com/eurheartj/article/39/33/3021/5079119 http://www.ncbi.nlm.nih.gov/pubmed/30165516?tool=bestpractice.com James (...) for all patients: weight loss, exercise, decreased sodium intake, Dietary Approaches to Stop Hypertension (DASH) diet, and moderation of alcohol consumption. Choice of drug therapy is often driven by considerations related to comorbid disease, but achievement of blood pressure goal may be accomplished with a variety of therapeutic agent(s). Definition Essential hypertension is defined as blood pressure (BP) ≥140/90 mmHg, with no secondary cause identified. National Heart, Lung, and Blood Institute

2018 BMJ Best Practice

35. Hypertension Evaluation History

Hg systolic and/or 90 mm Hg diastolic in patients without diabetes or chronic kidney disease, or blood pressure greater than 130 mm Hg systolic or 80 mm Hg diastolic in patients with diabetes or chronic kidney disease; Currently on pharmacological therapy for the treatment of hypertension. Definition (NCI) Blood pressure that is abnormally high. Definition (NCI_CTCAE) A disorder characterized by a pathological increase in blood pressure; a repeatedly elevation in the blood pressure exceeding 140 (...) PRESSURE , HYPERTENSION , PRESSURE, HIGH BLOOD , High blood pressure , Hyperpiesia , Hyperpiesis , Hypertensive vascular degeneration , Hypertensive vascular disease , BP - High blood pressure , High blood pressure disorder , Systemic arterial hypertension , HBP - High blood pressure , BP+ - Hypertension , HT - Hypertension , Hypertensive disorder, systemic arterial (disorder) , Hypertensive disorder , HTN - Hypertension , blood pressure; high , high; arterial tension , high; blood pressure

2018 FP Notebook

36. Idiopathic Generalized Exfoliative Dermatitis and Association with Antihypertensive Drugs and Statins: A Retrospective Case-Control Study. (Abstract)

. Idiopathic GED cases had consistent clinical and histological features but no apparent cause despite comprehensive evaluation. Controls were randomly selected from inpatients with other dermatological conditions in a 1: 1 ratio during the same period. Their relationship was analysed using univariate (χ2 or Fisher exact tests) and multivariate logistic regression analysis.There were 78 cases and 83 controls. Of the 78 cases, 42 patients had a history of treatment with antihypertensive drugs or statins (...) Idiopathic Generalized Exfoliative Dermatitis and Association with Antihypertensive Drugs and Statins: A Retrospective Case-Control Study. We aim to examine the hypothesis that antihypertensive drugs and statins may be responsible for the development of idiopathic generalized exfoliative dermatitis (GED) with a case-control study.All inpatients who were hospitalized under the dermatology service at the Tan Tock Seng Hospital, Singapore, between 1 May 2013 and 31 May 2015, were analysed

2019 Dermatology

37. Impact of a History of Hypertension in Pregnancy on Later Diagnosis of Atrial Fibrillation Full Text available with Trip Pro

Impact of a History of Hypertension in Pregnancy on Later Diagnosis of Atrial Fibrillation Atrial fibrillation/flutter (AF) produces significant morbidity in women and is typically attributed to cardiac remodeling from multiple causes, particularly hypertension. Hypertensive pregnancy disorders (HPDs) are associated with future hypertension and adverse cardiac remodeling. We evaluated whether women with AF were more likely to have experienced a HPD compared with those without.A nested case (...) with AF are more likely to have had a HPD, a relationship at least partially mediated by associated obesity and hypertension. Given the high morbidity of AF, studies evaluating the benefit of screening for and management of cardiovascular risk factors in women with a history of HPD should be performed.© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

2018 Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

38. Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes. Full Text available with Trip Pro

Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes. The arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis. However, approximately half of AVFs fail to mature. The use of angiotensin converting enzyme inhibitors (ACE-Is), angiotensin receptor blockers (ARBs), and calcium channel blockers (CCBs) exerts favorable endothelial effects and may promote AVF maturation. We tested associations of ACE-I and ARBs, CCBs, beta-blockers (...) failure (with or without intervention) occurred in 30.1%. After covariate adjustment, CCB use was associated with a 25% lower risk of overall AVF maturation failure (95% CI 3%-41% lower) but a non-significant 10% lower risk of unassisted maturation failure (95% CI 23% lower to 5% higher). ACE-I/ARB, beta-blocker, and diuretic use was not significantly associated with AVF maturation outcomes. None of the antihypertensive medication classes were associated with changes in AVF diameter or blood flow over

2018 American journal of nephrology

39. Autonomic and Vascular Control in Prehypertensive Subjects with a Family History of Arterial Hypertension Full Text available with Trip Pro

Autonomic and Vascular Control in Prehypertensive Subjects with a Family History of Arterial Hypertension Individuals with a family history of systemic arterial hypertension (FHSAH) and / or prehypertension have a higher risk of developing this pathology.To evaluate the autonomic and vascular functions of prehypertensive patients with FHSAH.Twenty-five young volunteers with FHSAH, 14 normotensive and 11 prehypertensive subjects were submitted to vascular function evaluation by forearm vascular (...) conductance(VC) during resting and reactive hyperemia (Hokanson®) and cardiac and peripheral autonomic modulation, quantified, respectively, by spectral analysis of heart rate (ECG) and systolic blood pressure (SBP) (FinometerPRO®). The transfer function analysis was used to measure the gain and response time of baroreflex. The statistical significance adopted was p ≤ 0.05.Pre-hypertensive individuals, in relation to normotensive individuals, have higher VC both at rest (3.48 ± 1.26 vs. 2.67 ± 0.72 units

2018 Arquivos brasileiros de cardiologia

40. Diagnosis of chronic thromboembolic pulmonary hypertension: A Canadian Thoracic Society clinical practice guideline update

hypertension Pulmonary hypertension (PH) is a serious condition of the pulmonary blood vessels characterized by increased pulmonary arterial pressure (PAP) and is often associated with progressive right ventricular (RV) failure and a high risk of death. PH is increasingly recognized as an important cause of dyspnea and exercise limitation in many patients. As per the current World Health Organization (WHO) PH classification updated at the Sixth World Symposium on Pulmonary Hypertension held in 2018 in Nice (...) with previous pulmonary embolism. Thromb Res. 2009;124(3):256–258. 10. Gary T, Starz I, Belaj K, et al. Hyperlipidemia is associated with a higher pulmonary artery systolic pressure in patients after pul- monary embolism. Thromb Res. 2012;129(1):86–88. 11. Giuliani L, Piccinino C, D’Armini MA, et al. Prevalence of undiag- nosed chronic thromboembolic pulmonary hypertension after pul- monary embolism. Blood Coagul Fibrinolysis. 2014;25(7):649–653. 12. Gu erin L, Couturaud F, Parent F, et al. Prevalence

2019 Canadian Thoracic Society

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>